DiaSorin S.p.A.
DIA
Rank in Stocks
#3801
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Share Price
$88.31
Last synced: 2026-10-21
Market Cap
$4.37B
Change (1 day)
-6.35%
Change (1 year)
-2.42%
Country
IT
Trade DiaSorin S.p.A. (DIA)
Category
Healthcare
Stock price history for DiaSorin S.p.A. (DIA)
Highest end of day price: $91.08 on 2026-10-01
Lowest end of day price: $16.82 on 2007-07-01
Lowest end of day price: $16.82 on 2007-07-01
Stock price history of DiaSorin S.p.A. from 2007 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 9.72% |
| 2025 | -30.70% |
| 2024 | 7.93% |
| 2023 | -28.26% |
| 2022 | -28.69% |
| 2021 | -5.96% |
| 2020 | 55.52% |
| 2019 | 60.48% |
| 2018 | -9.14% |
| 2017 | 60.80% |
| 2016 | 6.78% |
| 2015 | 29.22% |
| 2014 | -10.91% |
| 2013 | 19.58% |
| 2012 | 46.86% |
| 2011 | -38.72% |
| 2010 | 21.12% |
| 2009 | 94.79% |
| 2008 | -5.47% |
| 2007 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.76 | 53.69% |
CN
|
|
| $177.93 | 21.98% |
US
|
